SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3,113.04 |
| Enterprise Value ($M) | 2,819.75 |
| Book Value ($M) | 647.93 |
| Book Value / Share | 9.46 |
| Price / Book | 4.80 |
| NCAV ($M) | 434.31 |
| NCAV / Share | 6.34 |
| Price / NCAV | 7.17 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.33 |
| Return on Assets (ROA) | -0.47 |
| Return on Equity (ROE) | -0.60 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.54 |
| Current Ratio | 6.54 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 569.07 |
| Assets | 782.69 |
| Liabilities | 134.77 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 36.13 |
| Operating Income | -272.07 |
| Net Income | -215.33 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -185.84 |
| Cash from Investing | -220.22 |
| Cash from Financing | 494.01 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Wellington Management Group Llp | 5.10 | 74.06 | |
| 13G | Commodore Capital Lp | 5.50 | 11.94 | |
| 13G/A | Flynn James E | 4.98 | 12.87 | |
| 13G/A | Samlyn Capital, Llc | 3.80 | -23.50 | |
| 13G | Rtw Investments, Lp | 6.10 | ||
| 13G | Fmr Llc | 9.99 | ||
| 13G/A | Incyte Corp | 1.50 | -74.83 | |
| 13G/A | Federated Hermes, Inc. | 3.98 | -36.83 | |
| 13G/A | Biotechnology Value Fund L P | 4.80 | -7.59 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 331,812 | 986,847 | 33.62 | |
| 225,318 | 698,003 | 32.28 | |
| 165,608 | 646,769 | 25.61 | |
| 132,552 | 412,395 | 32.14 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MIRM – Mirum Pharmaceuticals, Inc. | MNKD – MannKind Corporation |
| MNOV – MediciNova, Inc. | MURA – Mural Oncology plc |
| NAII – Natural Alternatives International, Inc. |
Financial data and stock pages provided by
Fintel.io